CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals.
CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals. Knoxville, TN-based CPS will provide an ECAT PET scanner.
Sparked by Mobile PET Systems successful debut of mobile PET services at the October European Association of Nuclear Medicine meeting in Barcelona, Spain, the deal makes San Diego, CA-based Mobile PET the first company to provide mobile ECAT PET imaging technology in Europe, the two firms said. Mobile PET expects to begin service within the next three months through Mobile PET Systems Europe, a joint venture it formed with Neuromed of Germany.
The deal adds to the momentum Mobile PET has been enjoying since December 1998 when the company went public, bolstered by a favorable reimbursement market for PET. In February, the firm bought five mobile coaches from Calumet Coach of Calumet City, IL, expanding its service capability, and in March, received a $10 million line of credit from Finova Capital, which it has used to cover the purchase of five Siemens ECAT Exact PET cameras (SCAN 2/17/99 and 3/31/99).
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.